Kết quả tìm kiếm - Rob van Maanen

  • Đang hiển thị 1 - 7 kết quả của 7
Tinh chỉnh kết quả
  1. 1
    Hypothesis: mPGES-1-Derived Prostaglandin E2, a So Far Missing Link in COVID-19 Pathophysiology?

    Hypothesis: mPGES-1-Derived Prostaglandin E2, a So Far Missing Link in COVID-19 Pathophysiology? Bằng Jan Smeitink, Xiaolan Jiang, S. A. Pecheritsyna, G. Herma Renkema, Rob van Maanen, Julien Beyrath

    Được phát hành 2020
    lấy văn bản
    Pré-impressão
    Lưu vào danh sách
    Đã lưu trong:
  2. 2
    Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (<scp>SYNERGY</scp> study)

    Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (<scp>SYNERGY</scp> study) Bằng Sender Herschorn, Christopher R. Chapple, Paul Abrams, Salvador Arlandis, David Mitcheson, Kyu‐Sung Lee, Arwin Ridder, Matthias Stoelzel, Asha Paireddy, Rob van Maanen, Dudley Robinson

    Được phát hành 2017
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  3. 3
    Safety and Efficacy of Fidaxomicin and Vancomycin in Children and Adolescents with <i>Clostridioides (Clostridium) difficile</i> Infection: A Phase 3, Multicenter, Randomized, Single-blind Clinical Trial (SUNSHINE)

    Safety and Efficacy of Fidaxomicin and Vancomycin in Children and Adolescents with <i>Clostridioides (Clostridium) difficile</i> Infection: A Phase 3, Multicenter, Randomized, Sing... Bằng Joshua Wolf, Krisztina Kalocsai, Clàudia Fortuny, Ştefan Lazăr, Samantha Bosis, Bartosz Korczowski, Arnaud Petit, Daniel Bradford, Rodney Croos‐Dabrera, Elodie Incera, Joost Melis, Rob van Maanen

    Được phát hành 2019
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  4. 4
    Long-term Safety and Efficacy of Mirabegron and Solifenacin in Combination Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II)

    Long-term Safety and Efficacy of Mirabegron and Solifenacin in Combination Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (S... Bằng Christian Gratzke, Rob van Maanen, Christopher R. Chapple, Paul Abrams, Sender Herschorn, Dudley Robinson, Arwin Ridder, Matthias Stoelzel, Asha Paireddy, Sang Jin Yoon, С Х Аль-Шукри, Tomasz Rechberger, Elizabeth R. Mueller

    Được phát hành 2018
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  5. 5
    Modulation of the Renin-Angiotensin System against COVID-19: A path forward?

    Modulation of the Renin-Angiotensin System against COVID-19: A path forward? Bằng Serge Camelo, Waly Dioh, J. Pedro Teixeira, Laurence W. Busse, Girish B. Nair, Gaëtan Plantefève, Capucine Morélot-Panzini, Suzana Margareth Lobo, Wesley H. Self, Sean P. Collins, Rob van Maanen, Stanislas Veillet

    Được phát hành 2025
    lấy văn bản
    Revisão
    Lưu vào danh sách
    Đã lưu trong:
  6. 6
    Challenges in developing Geroscience trials

    Challenges in developing Geroscience trials Bằng Yves Rolland, Felipe Sierra, Luigi Ferrucci, Nir Barzilai, Rafael de Cabo, Joan B. Mannick, Anthony A. Oliva, William J. Evans, Davide Angioni, Philipe de Souto Barreto, Jérémy Raffin, Bruno Vellas, James L. Kirkland, Sandrine Andrieu, Daniel Bacqueville, Heike A. Bischoff‐Ferrari, Guillaume Blivet, Timothy P. Cash, Ana-Maria Cuervo, Noélie Davezac, Andrea Dimet‐Wiley, Alexander Fleming, Friedlander Gérard, Mitzi M. Gonzales, Sophie Guyonnet, Joshua M. Hare, Suzanne Hendrix, Christian Jørgensen, Matt Kaeberlein, Mehmood Khan, Stephen B. Kritchevsky, Aksana Labokha, Olivier Lairez, Stephanie Lederman, Jean Mariani, Lefkos Middleton, John C. Newman, Angelo Parini, Susan Peschin, Marco Prunotto, Sami Sagol, Suzanne M. Tomlinson, Georg C. Terstappen, Jacques Touchon, Cendrine Tourette, Rob van Maanen, Eric Verdin, Stan Watowich, Lei Zhang, Alex Zhavoronkov

    Được phát hành 2023
    lấy văn bản lấy văn bản
    Revisão
    Lưu vào danh sách
    Đã lưu trong:
  7. 7
    Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial

    Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial Bằng Suzana Margareth Lobo, Gaëtan Plantefève, Girish B. Nair, Adilson Joaquim Westheimer Cavalcante, Nara Franzin de Moraes, Estêvão Portela Nunes, Otis Barnum, Claudio Stadnik, Maria Patelli Juliani Souza Lima, Muriel Lins, Ludhmila Abrahão Hajjar, Christopher A. Lipinski, Shaheen Islam, Fabiano Ramos, Tiago Simon, Jean‐Benoît Martinot, Thomas Guimard, Arnaud Desclaux, Bertrand Lioger, Fernando Carvalho Neuenschwander, Bruno DeSouza Paolino, Alpesh Amin, Samuel Amil Acosta, Daniel F. Dilling, Edgardo Cartagena, Brian D. Snyder, Edouard Devaud, Ana Karolina Barreto Berselli Marinho, Suzana Érico Tanni, Patricia Medeiros Milhomem Beato, S. De Wit, V. Saravana Selvan, Jeffrey A. Gray, Ricardo Fernández, Valérie Pourcher, Lee Maddox, Richard Kay, Anait Azbekyan, Mounia Chabane, Cendrine Tourette, Luis Everton Esmeraldino, Pierre J. Dilda, René Lafont, Jean Mariani, Serge Camelo, Sandrine Rabut, Samuel Agus, Stanislas Veillet, Waly Dioh, Rob van Maanen, Capucine Morélot‐Panzini

    Được phát hành 2024
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:

Công cụ tìm kiếm: